11.57
price up icon0.61%   0.07
after-market Dopo l'orario di chiusura: 11.56 -0.010 -0.09%
loading

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

pulisher
Dec 21, 2024

Barclays PLC Purchases 75,609 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 21, 2024
pulisher
Dec 20, 2024

Mayukh Sukhatme Sells 412,584 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Roivant sciences executive sells common shares worth $4.97 million By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 20, 2024

Roivant sciences executive sells common shares worth $4.97 million - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Geode Capital Management LLC Acquires 1,460,205 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Retirement Systems of Alabama - MarketBeat

Dec 19, 2024
pulisher
Dec 17, 2024

Ramaswamy Urges BuzzFeed to Cut Jobs, Air More Conservative Voices - MSN

Dec 17, 2024
pulisher
Dec 16, 2024

Trump administration will have financial ties to biotechs - BioCentury

Dec 16, 2024
pulisher
Dec 12, 2024

State Street Corp Buys 1,118,561 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 12, 2024
pulisher
Dec 09, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 09, 2024
pulisher
Dec 07, 2024

What is Leerink Partnrs' Estimate for ROIV Q3 Earnings? - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

Several Positive Developments Lifted Roivant (ROIV) in Q3 - Insider Monkey

Dec 06, 2024
pulisher
Dec 06, 2024

Edgestream Partners L.P. Buys Shares of 48,226 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 762,953 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

MetLife Investment Management LLC Has $2.60 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Roivant to stop lung disease drug development after trial failure - MSN

Dec 04, 2024
pulisher
Dec 04, 2024

Roivant Sciences: A Biotech Growth Play With Major Ambitions (NASDAQ:ROIV) - Seeking Alpha

Dec 04, 2024
pulisher
Dec 04, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Holdings Cut by Melqart Asset Management UK Ltd - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Maven Securities LTD Purchases Shares of 400,000 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Charles Schwab Investment Management Inc. Buys 646,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Roivant Phase II miss for namilumab - The Pharma Letter

Dec 03, 2024
pulisher
Dec 03, 2024

Erste Asset Management GmbH Buys New Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Roivant Sciences Ends Namilumab Study Due to Inefficacy - TipRanks

Dec 03, 2024
pulisher
Dec 03, 2024

Roivant falls as lung disease drug fails in mid-stage study - XM

Dec 03, 2024
pulisher
Dec 02, 2024

TOMS Capital Investment Management LP Invests $46.33 Million in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

Thrivent Financial for Lutherans Sells 62,228 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 01, 2024
pulisher
Nov 29, 2024

Fmr LLC Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 29, 2024
pulisher
Nov 27, 2024

Rubric Capital Management LP Sells 600,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Loomis Sayles & Co. L P Has $45.15 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 26, 2024
pulisher
Nov 23, 2024

Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

Roivant Sciences president Eric Venker sells $1.13 million in shares By Investing.com - Investing.com Nigeria

Nov 22, 2024
pulisher
Nov 22, 2024

Roivant Sciences president Eric Venker sells $1.13 million in shares - Investing.com

Nov 22, 2024
pulisher
Nov 22, 2024

Thompson Siegel & Walmsley LLC Takes $5.93 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 22, 2024
pulisher
Nov 20, 2024

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution - Yahoo Finance

Nov 19, 2024
pulisher
Nov 18, 2024

Principal Financial Group Inc. Trims Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Vivek Ramaswamy's Net Worth Is 9 Figures—See How the DOGE Co-Lead Made His Millions - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Andreas Halvorsen's Recent Transaction in Roivant Sciences Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. (ROIV) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Vivek Ramaswamy: 10 things you ought to know about Trump's DOGE co-lead - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd - Reuters

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR

Nov 14, 2024
pulisher
Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English

Nov 13, 2024
pulisher
Nov 13, 2024

The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga

Nov 13, 2024
pulisher
Nov 13, 2024

How Vivek Ramaswamy Became A Billionaire - Forbes

Nov 13, 2024
pulisher
Nov 13, 2024

Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times

Nov 13, 2024
pulisher
Nov 13, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):